This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Lung cancer immunotherapy: progress, pitfalls, and promises
Molecular Cancer Open Access 21 February 2023
-
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Stem Cell Research & Therapy Open Access 28 July 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original articles
Choe, J. H. et al. Multi-antigen recognition circuits overcome challenges of specificity, heterogeneity, and durability in T cell therapy for glioblastoma. Preprint at bioRxiv https://doi.org/10.1101/2021.01.07.425632 (2021)
Hyrenius-Wittsten, A. et al. Enhanced solid tumor recognition and T cell stemness with SynNotch CAR circuits. Preprint at bioRxiv https://doi.org/10.1101/2021.01.06.425642 (2021)
Related article
Saffern, M. Oxford–Mount Sinai (OxMS) Preprint Journal Club. OxMS https://www.preprintclub.com/2021-jan-choe (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saffern, M., Samstein, R. Taking CAR T cells up a synthetic Notch. Nat Rev Immunol 21, 135 (2021). https://doi.org/10.1038/s41577-021-00514-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-021-00514-1
This article is cited by
-
Lung cancer immunotherapy: progress, pitfalls, and promises
Molecular Cancer (2023)
-
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Stem Cell Research & Therapy (2021)